Factors predicting drop out from, and retention in, specialist drug treatment services: A case control study in the North West of England

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Beynon, Caryl M ^a   McMinn, Alison M ^b   Marr, Adam J E ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b MRC EPIDEMIOLOGY UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEALTH SERVICE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MULTIVARIATE ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; ADDICTION; ADOLESCENT; AGE; COMPARATIVE STUDY; CULTURAL DEPRIVATION; DRUG DEPENDENCE TREATMENT; ETHNOLOGY; FACTUAL DATABASE; MIDDLE AGED; PATIENT; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CULTURAL DEPRIVATION; DATABASES, FACTUAL; ENGLAND; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT DROPOUTS; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE DETECTION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 44849099187     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-149     Document Type: Article

References (36)

1. The Global Burden. World Health Organization, http://www.who.int/ substance_abuse/facts/global_burden/en/index.html
2. Updated Drug Strategy 2002. Home Office Drugs Strategy Directorate, London, Home Office Drugs Strategy Directorate 2002
3. Tackling Drugs to Build a Better Britain. The Government's Ten-Year Strategy for Tackling Drugs Misuse. Department of Health, London, Stationery Office 1998
4. Business Plan. National Treatment Agency for Substance Misuse, London, National Treatment Agency for Substance Misuse 2006
5. Statistics for drug treatment activity in England 2006/07. National Drug Treatment Monitoring System. National Treatment Agency for Substance Misuse, http://www.nta.nhs.uk/media/media_releases/2007_media_releases/ statistics_for_drug_treatment_activity_in_england_2006_07_statistical_ release_181007.aspx
6. Treatment retention and 1 year outcomes for residential programmes in England. M Gossop J Marsden D Stewart A Rolfe, Drug and Alcohol Dependence 1999 57 89 98 10.1016/S0376-8716(99)00086-1 10617094
7. Drug abuse treatment process components that improve retention. DD Simpson GW Joe GA Rowan-Szal JM Greener, Journal of Substance Abuse Treatment 1997 14 565 572 10.1016/S0740-5472(97)00181-5 9437628
8. Predicting posttreatment cocaine abstinence for first-time admissions and treatment repeaters. YI Hser V Joshi MD Anglin B Fletcher, American Journal of Public Health 1999 89 666 671 10224976
9. Relationship between counselling rapport and drug abuse treatment outcomes. GW Joe DD Simpson DF Dansereau GA Rowan-Szal, Psychiatric Services 2001 52 1223 1229 10.1176/appi.ps.52.9.1223 11533397
10. Relationship between drug treatment services, retention, and outcomes. YI Hser E Evans D Huang MD Anglin, Psychiatric Services 2004 55 767 774 10.1176/appi.ps.55.7.767 15232015
11. Towards treatment effectiveness. National Treatment Agency for Substance Misuse, London, National Treatment Agency for Substance Misuse 2007
12. Improving treatment effectiveness through improvements in early retention - the measurement of attrition. National Treatment Agency for Substance Misuse, London, National Treatment Agency for Substance Misuse 2005
13. Effects of program and patient characteristics on retention of drug treatment patients. YI Hser V Joshi M Maglione CP Chou MD Anglin, Evaluation and Program Planning 2001 24 331 341 10.1016/S0149-7189(01)00027-1
14. Hidden need for drug treatment services: measuring problematic drug use in the North West of England. C Beynon MA Bellis T Millar P Meier R Thomson K Mackway-Jones, Journal of Public Health Medicine 2001 21 286 291 11873890
15. Statistics for drug treatment activity in England 2005/06 from the National Drug Treatment Monitoring System. National Treatment Agency for Substance Misuse, http://www.nta.nhs.uk/
16. Models of Care for Substance Misuse. National Treatment Agency for Substance Misuse, London, National Treatment Agency for Substance Misuse 2002
17. The English Indices of Deprivation 2004: Summary (revised). Office of the Deputy Prime Minister, London, Office of the Deputy Prime Minister
18. Trends in drop out, drug free discharge and rates of representation: a retrospective cohort study of drug treatment clients in the North West of England. CM Beynon MA Bellis J McVeigh, BMC Public Health 2006 6 205 213 16904004 10.1186/1471-2458-6-205
19. A short introduction to STATA 8 for biostatistics. M Hills BL De Stavola, London, Timberlake Consultants Ltd. 2003
20. KS06 Ethnic group. Office of National Statistics, http://www.statistics. gov.uk/statbase/Expodata/Spreadsheets/D6561.xls
21. Black and minority ethnic communities in England: a review of the literature on drug use and related service provision. National Treatment Agency for Substance Misuse, London, National Treatment Agency for Substance Misuse 2003
22. Young Asians and drug use. K Patel C Wibberley, Journal of Child Health Care 2002 6 51 59 12036177
23. Addressing the needs of cultural minorities in drug treatment. P Finn, Journal of Substance Abuse Treatment 1994 11 325 337 10.1016/0740-5472(94)90043- 4 7966503
24. Support for the effectiveness of culturally competent drug and alcohol treatment, policy planning and programme development. M Ellis, Journal of Substance Use 1999 4 35 40 10.3109/14659899909052893
25. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. HM Rhoades D Creson R Elk J Schmitz J Grabowski, American Journal of Public Health 1998 88 34 39 9584030
26. Where wealth means health: illustrating inequality in the North West. J Wood T Hennell A Jones J Hooper K Tocque MA Bellis, Liverpool, North West Public Health Observatory 2006
27. Is there a progression from abuse disorders to dependence disorders? TA Ridenour LB Cottler WM Compton EL Spitznagle RM Cunningham-Williams, Addiction 2003 98 635 644 10.1046/j.1360-0443.2003.00350.x 12751981
28. Distance travelled to outpatient drug treatment and client retention. K Beardsley ED Wish DB Fitzelle K O'Grady AM Arria, Journal of Substance Abuse Treatment 2003 25 279 285 10.1016/S0740-5472(03)00188-0 14693257
29. Treatment effectiveness: demonstration analysis of treatment surveillance data about treatment completion and retention. National Drug Evidence Centre, London, National Treatment Agency for Substance Misuse 2004
30. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. M Gossop J Marsden D Stewart T Kidd, Addiction 2003 98 291 303 10.1046/j.1360-0443.2003.00296.x 12603229
31. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. M Gossop D Stewart S Treacy J Marsden, Addiction 2002 97 39 47 10.1046/j.1360-0443.2002.00079.x 11895269
32. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990 - 98. PO Coffin S Galea J Ahern AC Leon D Vlahov K Tardiff, Addiction 2003 98 739 747 10.1046/j.1360-0443.2003.00376.x 12780362
33. Shooting Up: Infections among injecting drug users in the United Kingdom 2005. Health Protection Agency Health Protection Scotland National Public Health Service for Wales CDSC Northern Ireland CRDHB and the UASSG, London, Health Protection Agency 2006
34. Individuals stating alcohol as a secondary or tertiary problematic substance in contact with treatment services in the North West during 2006/07. A Khundakar M Morleo K Khundakar A Marr J McVeigh MA Bellis, Liverpool, Liverpool John Moores University 2007
35. Community Sentences Digest. E Solomon M Rutherford, London, Kings College 2007
36. Pathways in the relapse - treatment - recovery cycle over 3 years. CK Scott MA Foss ML Dennis, Journal of Substance Abuse Treatment 2005 28 2 Suppl 1 S63 S72 10.1016/j.jsat.2004.09.006 15797640